Skip to main content
Pathway Medicine

Search form

GoozyGooz

Become an Author
Recommended Reading
About this Resource

You are here

Home » Pharmacology » Antibacterials » Bacterial Cell Wall Synthesis Inhibitors » Beta-lactam Antibiotics

Book navigation

  • Immunology
  • Microbiology
  • Cardiovascular Medicine
  • Respiratory Medicine
  • Renal Medicine
  • Gastrointestinal Medicine
  • Hepatology
  • Endocrinology
  • Hematology and Oncology
  • Dermatology
  • Musculoskeletal System
  • Pharmacology
    • Basic Pharamacology
    • Antibacterials
      • Bacterial Cell Wall Synthesis Inhibitors
        • Beta-lactam Antibiotics
          • Penicillins
          • Cephalosporins
          • Carbapenems
          • Monobactams
        • Beta-lactamase Inhibitors
        • Vancomycin
      • Bacterial Ribosome Inhibitors
      • Bacterial Gyrase Inhibitors (Fluoroquinolones)
      • Bacterial Metabolism Inhibitors
      • Tuberculosis Chemotherapeutics
      • Leprosy Chemotherapeutics
    • Antivirals
    • Antifungals
    • Antiprotozoals
    • Blood Pharmacology
    • Diuretics
    • GI Pharmacology
  • Basic Concepts
  • Genetic Disorders
  • Surgery
  • Neurology

Monobactams

Overview
  • The Monobactams are a structurally-related class of Beta-lactam Antibiotics. This class of drugs is resistant to beta-lactamases.
Spectrum
  • The monobactams do not have any activity against gram positives or anaerobic bacteria. However, they are highly effective against certain gram negative bacteria, especially the enteric gram negative rods and can be used for Pseudomonas aeruginosa.
Member Drugs
  • Aztreonam
‹ Carbapenems up Beta-lactamase Inhibitors ›
Copyright 2010-2017 by Pathway Medicine
Terms of Use